Data from the Phase 3 RAY (MCL3001) study, an investigational clinical trial, showed oral IMBRUVICA® (ibrutinib) significantly improved progression-free survival (PFS; the primary endpoint)...

TopBuild Corp. (NYSE: BLD), the leading installer and distributor of insulation products to the United States construction industry, announced that Robert Buck, President and Chief Operating...

Digital Turbine, Inc. (Nasdaq: APPS), the company empowering operators and Original Equipment Manufacturers (OEMs) around the globe with end-to-end mobile solutions, today announced that...

Salesforce (NYSE: CRM), the Customer Success Platform and world's #1 CRM company, today announced that Salesforce executives will participate in the following investor events: Tuesday, Dec. 8,...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and...